During the past decade, Institute of Psychiatry, King's College London conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 3 clinical trials were completed, i.e. on average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of Psychiatry, King's College London" #1 sponsor was "King's College London" with 17 trials, followed by "Institute of Psychiatry, London" with 5 trials sponsored, "COMPASS Pathways" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Psychiatry, King's College London" #1 collaborator was "South London and Maudsley NHS Foundation Trust" with 7 trials as a collaborator, "Action on Addiction" with 2 trials as a collaborator, "NHS Lambeth Clinical Commissioning Group" with 2 trials as a collaborator, "Alzheimer's Society" with 1 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Psychiatry, King's College London" are "Alzheimer's Disease" (3 trials), "Major Depressive Disorder" (3 trials), "Schizophrenia" (3 trials), "Alcohol Abuse" (2 trials) and "Amyotrophic Lateral Sclerosis" (2 trials). Many other conditions were trialed in "Institute of Psychiatry, King's College London" in a lesser frequency.

Most popular intervention types in "Institute of Psychiatry, King's College London" are "Drug" (15 trials), "Behavioral" (7 trials), "Other" (6 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Donepezil" (3 trials), "Psilocybin" (3 trials), "Intermittent Theta Burst Stimulation" (2 trials), "Memantine" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Psychiatry, King's College London" are 31 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Institute of Psychiatry, King's College London". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Institute of Psychiatry, King's College London, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Psychiatry, King's College London, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".